Pharma CVCs have achieved an impressive exit record on the back of successes balancing tools in the innovation toolkit over the past 20 years

Medicine has a tradition of external innovation that predates much pharmaceutical CVC activity. It is perhaps best illustrated by the number of revenue-generating drugs with origins outside the vendor’s own research and development operation, often building on the input of government-funded research and expertise from universities. Development in many cases started with a smaller developer…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.